Quality assured
Confidentiality assured
Custom research services
The global cell cytometry market was worth approximately $5.27 billion in 2022 and is expected to maintain steady growth in the forthcoming years.
Market Overview
The cell cytometry market is a rapidly growing market, driven by the rising prevalence of cancer, immunodeficiency disorders, and infectious diseases. The market is also being driven by the increasing adoption of flow cytometry techniques in research activities, increasing public-private initiatives in immunology and immuno-oncology research, and the rising technological advancements in flow cytometry software.
The market is segmented by component (instruments, reagents, consumables, software, and services), technology (cell-based flow cytometry, bead-based flow cytometry), application (academic and clinical applications, diagnostic applications), and end-user (hospitals, medical schools, and clinical testing labs, commercial organizations, academic institutions, and others).
Key Report Finding
Market Drivers
Rapid technological advancement
Rising prevalence of cancer and other diseases
Cell cytometry is a powerful tool for the diagnosis, prognosis, and treatment of cancer and other diseases. The increasing prevalence of these diseases is driving the demand for cell cytometry.
Rising adoption of flow cytometry techniques in research activities
Flow cytometry is a versatile tool that can be used to study a wide variety of cellular processes. The rising adoption of flow cytometry techniques in research activities is driving market growth.
Increasing technological advancements in flow cytometry software
Flow cytometry software is becoming more user-friendly and powerful. This is making it more accessible to researchers and clinicians, which is driving the market growth.
Growing demand for bead-based flow cytometry
Bead-based flow cytometry is a novel technology that is becoming increasingly popular. This is due to its advantages over traditional cell-based flow cytometry, such as its speed, accuracy, and sensitivity.
Market Opportunities
The increasing prevalence of cancer and other diseases
As the prevalence of cancer and other diseases increases, the demand for cell cytometry is also expected to increase. Cell cytometry is a valuable tool for the diagnosis, prognosis, and treatment of these diseases.
Increasing demand for personalized medicine
With the growing need for personalized medicine, there is a growing need for cell cytometry to analyze individual cells and create personalized treatments.
Rising use of flow cytometry and single-cell analysis
Flow cytometry is becoming increasingly popular for use in immunoassay analyses. Moreover, single-cell analysis is becoming increasingly popular due to its ability to provide insights into cell behavior and function at a granular level.
Increasing use of mass spectrometry for cell analysis
Mass spectrometry is becoming a more popular tool for cell analysis due to its ability to provide detailed information about cells and their components.
Rising demand for automated cell analysis
There is a growing demand for automated cell analysis due to the need for faster, more efficient analysis and the need to analyze larger sample sizes.
Market Challenges
The complexity of the technology
Flow cytometers are expensive pieces of equipment. This can be a barrier to entry for some companies and institutions. Moreover, it can make it difficult to use and maintain, and it can also be difficult to interpret the data that is generated.
The need for specialized training
Flow cytometry requires specialized training. This can be a barrier to entry for some companies and institutions.
The lack of standardization
There is no single standard for flow cytometry. This can make it difficult to compare data from different laboratories.
The need for high-quality reagents and consumables
Flow cytometry requires high-quality reagents and consumables. This can be a cost barrier for some companies and institutions.
Regional Coverage
North America is the largest market for cell cytometry, followed by Europe and Asia Pacific. The growth of the market in North America is being driven by the increasing prevalence of cancer and the rising demand for cell-based research. The market in Europe is being driven by the increasing adoption of flow cytometry techniques in clinical applications and the rising demand for bead-based flow cytometry. The market in Asia Pacific is being driven by the rising prevalence of infectious diseases and the increasing demand for flow cytometry in academic research.
North America:
Europe:
Asia Pacific:
Latin America:
Middle East and Africa:
Company Recent Development
Cell Cytometry is highly competitive. The key players in the market include:
Becton, Dickinson, and Company (BD): Becton, Dickinson, and Company is a large medical technology company based in New Jersey with a global presence. As of 2022, the company has over 75,000 employees and operates in over 60 countries. BD's annual revenue is over $12 billion. The company provides a wide range of products and services to help prevent the spread of infection, such as needles, syringes, and IV catheters.
Danaher Corporation (Beckman Coulter Inc.): Danaher Corporation is a large technology and manufacturing company with a global presence. As of 2023, the company has over 81,000 employees and operates in over 60 countries. Danaher's annual revenue is over $25 billion. The company’s products and services are organized into four sections including diagnostics, life sciences, water quality monitoring, and product authenticity.
Sysmex Corporation: Sysmex Corporation is a medical equipment and diagnostics company headquartered in Kobe, Japan. As of 2023, the company has over 10,000 employees and operates in over 120 countries. Sysmex's annual revenue is over $2.5 billion. The company is a major player in the global clinical diagnostics market. The company's size and reach give it a significant advantage over its competitors.
Bio-Rad Laboratories Inc.: Bio-Rad Laboratories Inc. is a life science research and clinical diagnostics company headquartered in Hercules, California, United States. As of 2022, the company has over 7,900 employees and operates in over 60 countries. Bio-Rad's annual revenue is over $2.8 billion. The company provides products and services for cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education.
Luminex Corporation: Luminex Corporation is a medium-sized company with approximately 1,080 employees worldwide. The company is headquartered in Austin, Texas, and has offices in the United States, Europe, and Asia. Luminex's annual revenue is approximately $250 million. The company develops, manufactures, and markets biological testing technologies. Its flagship product is the xMAP® technology, which is a multiplexing platform that allows for the simultaneous analysis of multiple analytes in a single sample. Luminex's products are used in a variety of applications, including clinical diagnostics, pharmaceutical research, and biodefense.
The cell cytometry market is a rapidly growing market, and several market opportunities are present for companies that are active in this space. The market is poised to experience growth in the coming years due to the increasing demand for personalized medicine, the increasing use of flow cytometry for immunoassays, the growing popularity of single-cell analysis, the rising use of mass spectrometry for cell analysis, and the increasing demand for automated cell analysis.
Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.
View Methodology
Quality assured
Confidentiality assured
Custom research services
